1998
DOI: 10.1002/1529-0131(199804)41:4<758::aid-art37>3.0.co;2-4
|View full text |Cite
|
Sign up to set email alerts
|

Reply

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

1998
1998
1998
1998

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Overlap diseases of RA and SSc have been reported previously, but in most of those patients, scleroderma was not limited and, in contrast to the 3 patients reported herein, antibodies to topoisomerase, but not to centromere antigens, were detected (5,(12)(13)(14)(15)(16)(17)(18)(19). Raynaud's phenomenon had developed between 14 years before and 16 years after the occurrence of arthritis.…”
Section: Discussionmentioning
confidence: 50%
See 3 more Smart Citations
“…Overlap diseases of RA and SSc have been reported previously, but in most of those patients, scleroderma was not limited and, in contrast to the 3 patients reported herein, antibodies to topoisomerase, but not to centromere antigens, were detected (5,(12)(13)(14)(15)(16)(17)(18)(19). Raynaud's phenomenon had developed between 14 years before and 16 years after the occurrence of arthritis.…”
Section: Discussionmentioning
confidence: 50%
“…While the RA component was long-lasting and severe, the lcSSc component of the overlap disease occurred later, was mild, did not involve vital organs, and did not necessitate aggressive therapy. Thus, in contrast with other RA-scleroderma overlap patients (5,(12)(13)(14)(15)(16), the evolution of lcSSc in RA patients does not appear to constitute a bad prognostic sign.…”
Section: Discussionmentioning
confidence: 83%
See 2 more Smart Citations